Michael M. Murphy
Harvard University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Michael M. Murphy.
Cell | 2006
Raul Mostoslavsky; Katrin F. Chua; David B. Lombard; Wendy W. Pang; Miriam R. Fischer; Lionel Gellon; Pingfang Liu; Gustavo Mostoslavsky; Sonia Franco; Michael M. Murphy; Kevin D. Mills; Parin Patel; Joyce T. Hsu; Andrew L. Hong; Ethan Ford; Hwei Ling Cheng; Caitlin Kennedy; Nomeli P. Nunez; Roderick T. Bronson; David Frendewey; Wojtek Auerbach; David M. Valenzuela; Margaret Karow; Michael O. Hottiger; Stephen D. Hursting; J. Carl Barrett; Leonard Guarente; Richard C. Mulligan; Bruce Demple; George D. Yancopoulos
The Sir2 histone deacetylase functions as a chromatin silencer to regulate recombination, genomic stability, and aging in budding yeast. Seven mammalian Sir2 homologs have been identified (SIRT1-SIRT7), and it has been speculated that some may have similar functions to Sir2. Here, we demonstrate that SIRT6 is a nuclear, chromatin-associated protein that promotes resistance to DNA damage and suppresses genomic instability in mouse cells, in association with a role in base excision repair (BER). SIRT6-deficient mice are small and at 2-3 weeks of age develop abnormalities that include profound lymphopenia, loss of subcutaneous fat, lordokyphosis, and severe metabolic defects, eventually dying at about 4 weeks. We conclude that one function of SIRT6 is to promote normal DNA repair, and that SIRT6 loss leads to abnormalities in mice that overlap with aging-associated degenerative processes.
Molecular Cell | 2008
Gang Li; Frederick W. Alt; Hwei Ling Cheng; James W. Brush; Peter H. Goff; Michael M. Murphy; Sonia Franco; Yu Zhang; Shan Zha
Mutations in XLF/Cernunnos (XLF) cause lymphocytopenia in humans, and various studies suggest an XLF role in classical nonhomologous end joining (C-NHEJ). We now find that XLF-deficient mouse embryonic fibroblasts are ionizing radiation (IR) sensitive and severely impaired for ability to support V(D)J recombination. Yet mature lymphocyte numbers in XLF-deficient mice are only modestly decreased. Moreover, XLF-deficient pro-B lines, while IR-sensitive, perform V(D)J recombination at nearly wild-type levels. Correspondingly, XLF/p53-double-deficient mice are not markedly prone to the pro-B lymphomas that occur in previously characterized C-NHEJ/p53-deficient mice; however, like other C-NHEJ/p53-deficient mice, they still develop medulloblastomas. Despite nearly normal V(D)J recombination in developing B cells, XLF-deficient mature B cells are moderately defective for immunoglobulin heavy-chain class switch recombination. Together, our results implicate XLF as a C-NHEJ factor but also indicate that developing mouse lymphocytes harbor cell-type-specific factors/pathways that compensate for the absence of XLF function during V(D)J recombination.
Journal of Experimental Medicine | 2010
Shan Zha; Craig H. Bassing; Takaomi Sanda; James W. Brush; Harin Patel; Peter H. Goff; Michael M. Murphy; Suprawee Tepsuporn; Richard A. Gatti; A. Thomas Look; Frederick W. Alt
Ataxia telangiectasia mutated (ATM) deficiency predisposes humans and mice to T lineage lymphomas with recurrent chromosome 14 translocations involving the T cell receptor α/δ (Tcra/d) locus. Such translocations have been thought to result from aberrant repair of DNA double-strand breaks (DSBs) during Tcra locus V(D)J recombination, and to require the Tcra enhancer (Eα) for Tcra rearrangement or expression of the translocated oncogene. We now show that, in addition to the known chromosome 14 translocation, ATM-deficient mouse thymic lymphomas routinely contain a centromeric fragment of chromosome 14 that spans up to the 5′ boundary of the Tcra/d locus, at which position a 500-kb or larger region centromeric to Tcra/d is routinely amplified. In addition, they routinely contain a large deletion of the telomeric end of one copy of chromosome 12. In contrast to prior expectations, the recurrent translocations and amplifications involve V(D)J recombination–initiated breaks in the Tcrd locus, as opposed to the Tcra locus, and arise independently of the Eα. Overall, our studies reveal previously unexpected mechanisms that contribute to the oncogenic transformation of ATM-deficient T lineage cells.
Journal of Experimental Medicine | 2008
Sonia Franco; Michael M. Murphy; Gang Li; Tiffany Borjeson; Cristian Boboila; Frederick W. Alt
The DNA-dependent protein kinase catalytic subunit (DNA-PKcs) and Artemis are classical nonhomologous DNA end-joining (C-NHEJ) factors required for joining a subset of DNA double-strand breaks (DSB), particularly those requiring end processing. In mature B cells, activation-induced cytidine deaminase (AID) initiates class switch recombination (CSR) by introducing lesions into S regions upstream of two recombining CH exons, which are processed into DSBs and rejoined by C-NHEJ to complete CSR. The function of DNA-PKcs in CSR has been controversial with some reports but not others showing that DNA-PKcs–deficient mice are significantly impaired for CSR. Artemis-deficient B cells reportedly undergo CSR at normal levels. Overall, it is still not known whether there are any CSR-associated DSBs that require DNA-PKcs and/or Artemis to be joined. Here, we have used an immunoglobulin (Ig)H locus-specific fluorescent in situ hybridization assay to unequivocally demonstrate that both DNA-PKcs and, unexpectedly, Artemis are necessary for joining a subset of AID-dependent DSBs. In the absence of either factor, B cells activated for CSR frequently generate AID-dependent IgH locus chromosomal breaks and translocations. We also find that under specific activation conditions, DNA-PKcs−/− B cells with chromosomal breaks are eliminated or at least prevented from progressing to metaphase via a p53-dependent response.
Molecular Cell | 2006
Sonia Franco; Monica Gostissa; Shan Zha; David B. Lombard; Michael M. Murphy; Ali A. Zarrin; Catherine T. Yan; Suprawee Tepsuporn; Julio C. Morales; Melissa M. Adams; Zhenkun Lou; Craig H. Bassing; John P. Manis; Junjie Chen; Phillip B. Carpenter; Frederick W. Alt
Cell Metabolism | 2005
Katrin F. Chua; Raul Mostoslavsky; David B. Lombard; Wendy W. Pang; Shin'ichi Saito; Sonia Franco; Dhruv Kaushal; Hwei-Ling Cheng; Miriam R. Fischer; Nicole Stokes; Michael M. Murphy; Ettore Appella; Frederick W. Alt
Proceedings of the National Academy of Sciences of the United States of America | 2006
Julio C. Morales; Sonia Franco; Michael M. Murphy; Craig H. Bassing; Kevin D. Mills; Melissa M. Adams; Nicole Walsh; John P. Manis; George Z. Rassidakis; Frederick W. Alt; Phillip B. Carpenter
The Journal of Allergy and Clinical Immunology | 2008
Haifa H. Jabara; Jayanta Chaudhuri; Shilpee Dutt; Fatma Dedeoglu; Yu Weng; Michael M. Murphy; Sonia Franco; Fredrick W. Alt; John P. Manis; Raif S. Geha
Archive | 2008
Craig H. Bassing; Sheila Ranganath; Michael M. Murphy; Velibor Savic; Meagan Gleason; W Frederick
Cell Metabolism | 2006
Katrin F. Chua; Raul Mostoslavsky; David B. Lombard; Wendy W. Pang; Shin'ichi Saito; Sonia Franco; Dhruv Kaushal; Hwei Ling Cheng; Miriam R. Fischer; Nicole Stokes; Michael M. Murphy; Ettore Appella; Frederick W. Alt